Anand joined Karyopharm in June 2018 and leads the commercial preparation and launch activities for our novel product pipeline. In this capacity, he will build and lead our marketing, sales, market access and patient services functions in all geographies where will be establishing commercial operations.
Anand has built and led commercial and cross-functional operations and successfully launched and marketed novel therapeutics across a broad array of therapeutic areas. Most recently, Anand has provided commercial and strategic consultancy services to a variety of biotech companies and investors through his firm, Ignition Insights, LLC.
Prior to forming Ignition, he served as Chief Commercial Officer for Chiasma, Inc. where he started up commercial operations and built a launch-ready rare disease organization. Previously, Anand served in a progression of commercial leadership and general management roles at Amgen Inc. where he launched and led brands, business units and country operations in the U.S, Europe and Canada across the nephrology, rheumatology, dermatology, bone health and oncology therapeutic areas. Earlier in his career, Anand was a brand manager at Procter and Gamble Company for bone health and ulcerative colitis products.
Anand received an MBA from the Simon Business School at the University of Rochester and a B.A. in Zoology from The George Washington University.